期刊
NATURE BIOTECHNOLOGY
卷 22, 期 5, 页码 535-546出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt964
关键词
-
资金
- NCI NIH HHS [R33 CA97502] Funding Source: Medline
- NIGMS NIH HHS [R01 GM63090] Funding Source: Medline
Alternative splicing is the major source of proteome diversity in humans and thus is highly relevant to disease and therapy. For example, recent work suggests that the long-sought-after target of the analgesic acetaminophen is a neural-specific, alternatively spliced isoform of cyclooxygenase 1 (COX-1). Several important diseases, such as cystic fibrosis, have been linked with mutations or variations in either cis-acting elements or trans-acting factors that lead to aberrant splicing and abnormal protein production. Correction of erroneous splicing is thus an important goal of molecular therapies. Recent experiments have used modified oligonucleotides to inhibit cryptic exons or to activate exons weakened by mutations, suggesting that these reagents could eventually lead to effective therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据